Dan Gebow, PhD, is Chief Innovation Officer at Bioclinica. He leads digital transformation initiatives to drive technological change across the medical imaging business and accelerates the investment and productization of new tools for critical insights. He brings more than 18 years of experience in clinical research informatics and 28 years in biomedical research to this role.
Dr. Gebow joined Bioclinica in 2017 following the acquisition of his software company MDDX Research and Informatics, now known as the backbone of SMART Submit. He previously served as Senior Vice President of Research and Development and Vice President of Innovation at Bioclinica.
During his career, Dr. Gebow has brought over ten digital health tools from ideation to commercialization. In addition to numerous patent filings, he has authored several scientific publications, covering a range of topics including medical imaging and cancer genetics. He earned his Doctorate from Harvard University, with course work completed at Harvard Medical School, Harvard School of Public Health, and Massachusetts Institute of Technology (MIT).